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PRELIMINARY AND SHORT REPORTS
TREATMENT OF CHRONIC DISCOID LUPUS ERYTHEMATOSUS
WITH ATABRINEt
GEORGE C. WELLS, MB., M.R.C.P.
Treatment with Atabrine® has produced remissions in 9 out of 12 of the eases of chronic
discoid lupus erythematosus at present under observation at the University of Chicago
Out-Patient Clinic, and this is in agreement with the recent report of Page (1). Previously
Popoff and Kutinscheff (2) had noted remission of lupus erythematosus under treatment
with Atabrine® and presented 6 treated cases at a meeting of the Sofia Dermatological
Society in 1941.
Atabrine® 0.1 gm. is given three times a day by mouth until there is improvement of the
lupus erythematosus or until the skin is stained yellow, which is usually after about four
weeks of treatment. At this time paling of the lesions and diminution of scaling are usually
apparent and the dosage is reduced to 0.1 gm. daily which is continued for a further month
or two depending on the response. Patients are warned to expect yellowness of the skin
which will fade only gradually after discontinuing Atabrine®, and they are warned to stop
treatment at once if there should be any unusual symptom such as itching or gastro-in-
testinal disturbance.
CASE REPORTS
Cese 1: 5. J., a 53 year old widow, has had chronic discoid lupus erythematosus of the
scalp for three years and there has been no response to treatments with gold, bismuth or
quinine. Atabrine® 0.3 gm. daily for two weeks gave her headaches and she stopped treat-
ment for a week after which she was able to resume Atabrine® 0.1 gm. daily without dis-
comfort. After a month there was marked improvement, and after two months, the lesions
almost completely disappeared.
Cese 2: T. K., a 53 year old salesman, first had chronic discoid lupus erythematosus 13
years before on the ears, scalp and buccal mucosa. After treatment for a year in 1947, mainly
with gold salts, the lesions cleared completely and remained clear until two years ago,
since when the lupus erythematosus has gradually progressed. After taking 0.3 gm. Ata-
brine® daily for four weeks the lesions started to resolve and the skin was stained yellow.
The lesions gradually regressed after continuing on Atabrine® 0.1 gm. daily for two more
months.
Cose 3: 1. F., a 42 year old store-owner, has had chronic discoid lupus erythematosus
for 11 years, affecting the eyelids, face, lower lip and buccal mucosa. During the past 4
years his lower lip has been continuously swollen eroded and tender and there was little
response to treatment with heavy metals, quinine and cortisone. With Atabrine® 0.3 gm.
daily he improved after three weeks and reduced the dosage to 0.2 gm. daily and stopped
treatment after two weeks. Now, a month later, he is better than he has been in the last
eight years and for the first time his lip is not sore.
Cese 4: C. S., a 51 year old metallurgist, had recurrent discoid lupus erythematosus dur-
ing the summer months for the last four years, and gold injections helped resolution. This
year fresh discoid lesions appeared on the face and he was given Atabrine® 0.3 gm. daily.
After three weeks he developed acute diarrhea, left off treatment and then resumed Ata-
brine® 0.1 gm. daily for 4 weeks. As the skin became yellow, the lesions faded and disap-
peared completely.
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Case 5: II. B., a 32 year old housewife, has had chronic discoid lupus erythematosus of
the face, scalp and mouth for four years, and she has derived little benefit from treatments
with gold, bismuth, quinine, vitamin E, etc. Atahrine® 0.3 gm. daily produced remission
after one month, by which time the skin was stained yellow. Further treatment for two
months with 0.1 gm. daily has improved her condition to almost complete healing. Besides
paling and diminished sealing and flattening of the lesions, itching and burning have dis-
appeared. This is the first really good relief she has had in the past four years.
Case 6: H. E., a 42 year old salesman, has had lupus erythematosus of the face for the
past 12 years with provocation by sunlight. At first the lesions disappeared in the winter.
During the past six years the lesions have been more persistent and he has had many courses
of treatment with gold, bismuth and quinine with only moderate improvement. Treatment
with Atabrine® 0.3 gm. daily for nearly two months cleared the eruption completely.
Case 7: D. S., a 20 year old housewife, developed, two and one-half years ago, erythema
perstans over the nose, with burning sensation provoked by sunlight. Six months ago she
developed a scalp lesion with erythema scaling and hair loss. Atabrine® 0.3 gm. daily was
given for one month only. All signs of activity disappeared from the lesions.
Case 8: 0. 0., a 43 year old housewife, has had for one year chronic discoid lupus ery-
thematosus of the V of the neck and for one month several erythema perstans lesions of the
eyelids and cheeks. Treatment with 0.3 gm. Atabrine® daily for one month resulted in
complete disappearance of the lupus erythematosus. There has been no relapse during the
past two months in spite of moderate exposure to sunlight while playing golf.
Case 9: B. K., a 39 year old housewife, has had chronic discoid lupus erythematosus for
10 years on the forehead, ears and upper chest. She has been treated repeatedly with gold
and bismuth salts and with quinine, with some good remissions. This year she was given
0.3 gm. Atabrine® daily on account of active lupus erythematosus of the eyelid and ears.
After two months the lesions had completely disappeared. There was marked yellow stain-
ing of the skin which has gradually faded over the past six months without treatment. She
says she is better than at any time since 1944.
Case 10: F. D., a 46 year old confectioner, had chronic discoid lupus erythematosus of
the face 24 years ago for which he was treated with gold salts and after 18 months the les-
ions healed and remained so until relapse 7 years ago. Over the last three years he has had
repeated courses of gold and bismuth injections with no satisfactory effect. Atabrine®
0.3 gm. daily for two months caused marked staining of the skin, but there was no improve-
ment of the lupus erythematosus.
Case 11: E. 2., a 53 year old salesman, has had thickened chronic discoid lupus erythe-
matosus of his cheeks for four years. Neither gold nor bismuth injections seemed to be
beneficial; he had transient remission from a course of ACTH while in hospital two years
ago. lie was given Atabrine® 0.3 gm. daily but after three weeks developed urticaria which
subsided when Atabrine® was stopped. He rcsumedAtabrine® 0.2 gm. daily two months later,
hut after a week he got general pruritus together with erythema and scaling of the palms.
This was considered to be a drug reaction to Atabrine®, and the treatment was abandoned.
There was no improvement in this case.
Case 12: B. H., a 42 year old secretary, has had chronic discoid lupus erythematosus for
seventeen years, involving the face, scalp and neck. At first she had good remissions with
gold injections, but of late, treatments with gold, bismuth, quinine, vitamin B and corti-
sone have failed. With Atabrine® 0.2 gm. daily for one month there was improvement which
was maintained with 0.1 gm. daily for another month. But after this the lupus extended on
to the extensor aspects of the arms and there followed exudative lesions around the eyelids,
suggestive of sensitivity to Atabrine®.
coMMENT
Of 12 cases of chronic discoid lupus erythematosus, 9 showed a good response with sub-
stantial regression of lesions and of these 3 have cleared completely. Three cases failed to
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respond, and in one of these there was an Atabrine® drug eruption with itching and sealing
of the palms, and in one ease Atabrine® appeared to favor dissemination of the skin lupus
erythematosus. In the third failure there was no regression in spite of adequate intake of
Atabrine®.
The drug was used in one ease of severe disseminated lupus erythematosus of the face,
neck, arms and legs with slight systemic involvement. Response to Atabrine® was dramatic
and other eases of this kind are being studied.
During treatment, patients examined under filtered ultraviolet light show brighter fluo-
rescence in the lupus erythematosus than in the surrounding normal skin. Possibly there is
selective uptake of Atabrine® in the lesions.
While Atabrine® appears to be a most valuable therapeutic agent in chronic discoid
lupus erythematosus, it must he used with care in view of the idiosyncrasy of these patients
to a variety of drugs.
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